Pharma Focus America
Thermo Fisher Scientific - Chemical Products


Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area

Kamau Therapeutics Reveals Clinical-Stage Gene Correction Technology for Life-Threatening Genetic Diseases After Emerging from Stealth Mode

Friday, December 08, 2023

Kamau Therapeutics a company in the clinicalstage of gene correction has recently emerged from stealth mode following a strategic deal with Graphite Bio

Engeneic Has Been Granted "Fast-track" Designation by the FDA for Its Novel Armed Nanocell Drug Conjugate (ANDC) Aimed at Treating Pancreatic Cancer

Friday, December 08, 2023

EnGeneIC an innovative biopharmaceutical company leading the field of armed antibody therapeutics for oncology has achieved a significant milestone with the FDA granting FastTrack designation for its pancreatic cancer therapeutic

BioGenCell Announces the Launch of its Fifth Clinical Trial Site for Chronic Limb-Threatening Ischemia in the United States

Friday, December 08, 2023

BioGenCell a leader in the field of personalized cell therapy solutions is pleased to announce the commencement of its fifth Phase II clinical trial site in the United States at the University of Maryland Medical Center

Ten63 Therapeutics and Boehringer Ingelheim Enter Partnership for Multi-Target Drug Discovery

Thursday, December 07, 2023

Ten Therapeutics a biotechnology company has unveiled a collaboration with Boehringer Ingelheim for multitarget drug discovery The partnership aims to discover innovative therapeutic molecules to address diseases

Mendus and the Australasian Leukaemia & Lymphoma Group Collaborate to Broaden Clinical Trials Investigating Vididencel as a Maintenance Treatment for AML

Thursday, December 07, 2023

Mendus AB a biopharmaceutical company specializing in immunotherapies for tumor recurrence has recently disclosed a partnership with the Australasian Leukaemia Lymphoma Group

Osteal Therapeutics' VT-X7 Gets FDA Breakthrough Designation, Completes APEX-2 Trial Enrollment

Wednesday, December 06, 2023

Osteal Therapeutics has received Breakthrough Therapy Designation from the US Food and Drug Administration for VTX an investigational drug therapy targeting periprosthetic joint infection in the hip and knee

Merck KGAA, Darmstadt, Germany Expands Oncology Portfolio Through Collaboration Deal With Abbisko for Phase III Candidate, Pimicotinib

Tuesday, December 05, 2023

Merck KGaA Darmstadt Germany a leading science and technology company has recently unveiled a license agreement with Abbisko Therapeutics Co Ltd in Shanghai China for pimicotinib

Nona Biosciences and Lycia Therapeutics Establish Collaborative Partnership

Monday, December 04, 2023

Nona Biosciences a global leader in technology innovation and antibody discovery solutions recently announced a collaboration agreement with Lycia Therapeutics a company specializing in extracellular protein degradation

280Bio initiates Phase I Clinical Trial for TEB-17231, an Oral Pan-RAS Inhibitor, in Advanced Cancer Patients with KRAS, HRAS, or NRAS Mutations

Saturday, December 02, 2023

Bio Inc a biotechnology company in the clinical stage focused on developing precision oncology medicines has announced the initiation of treatment for the first patient with TEB a small molecule inhibitor designed

Phenomic and Astellas Establish Collaborative Research Initiative to Advance Solid Tumor Cell Therapies

Friday, December 01, 2023

Phenomic AI Inc a biotech company dedicated to developing therapies for stromarich tumors using its scTx singlecell transcriptomics platform has established a strategic research collaboration with Astellas Pharma Inc

ROUQETTE - Pharma Virtual Lab